9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine has been researched along with Experimental Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; De Clercq, E; Holy, A; Naesens, L; Neyts, J; Rosenberg, I | 1 |
1 other study(ies) available for 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and Experimental Leukemia
| Article | Year |
|---|---|
Efficacy of oral 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the treatment of retrovirus and cytomegalovirus infections in mice.
Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Cytomegalovirus Infections; Friend murine leukemia virus; Injections, Intraperitoneal; Leukemia, Experimental; Mice; Moloney murine sarcoma virus; Sarcoma, Experimental; Survival Rate; Treatment Outcome | 1993 |